GEICAM2003_2B | R Documentation |
Kaplan-Meier digitized data from GEICAM2003, figure 2B (PMID 26416999). A reported sample size of 1,384 for a primary endpoint of iDFS in breast cancer.
GEICAM2003_2B
A data frame of 1,384 observations and 3 variables:
time | event time (in years) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (ec_t, et_x) | |
Martín M, Ruiz Simón A, Ruiz Borrego M, et al. Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study. J Clin Oncol 2015; 33: 3788–95.
summary(GEICAM2003_2B)
kmplot(GEICAM2003_2B)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.